Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance
Background: As Parkinson's disease (PD) advances, management is challenged by an increasingly variable and inconsistent response to oral dopaminergic therapy, requiring special considerations by the provider. Continuous 24 h/day subcutaneous infusion of foslevodopa/foscarbidopa (LDp/CDp) provid...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Elsevier
2024-01-01
|
丛编: | Clinical Parkinsonism & Related Disorders |
主题: | |
在线阅读: | http://www.sciencedirect.com/science/article/pii/S2590112524000082 |